Griptha Putra Persada Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp59 (market cap 60B, 661.3K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 9.7× Griptha Putra Persada Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 661.3K). Which is the better fit depends on your goals.
| GRPH | LABS | |
|---|---|---|
Market Cap | 60B | 584.6B |
Volume | 661.3K | 817.3K |
Lot | 6.61K | 8.17K |
Turnover | 39.67M | 120.01M |
Average Price | 59.99 | 146.84 |
Value | 39.67M | 120.01M |
Indicative Equilibrium Price | 59 | 146 |
Indicative Equilibrium Volume | 640 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →